Atea Pharmaceuticals Inc (AVIR)
3.82
+0.21
(+5.82%)
USD |
NASDAQ |
May 22, 16:00
3.81
-0.01
(-0.26%)
After-Hours: 20:00
Atea Pharmaceuticals Price to Book Value: 0.6379 for May 22, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 22, 2024 | 0.6379 |
| May 21, 2024 | 0.6028 |
| May 20, 2024 | 0.6012 |
| May 17, 2024 | 0.6095 |
| May 16, 2024 | 0.6179 |
| May 15, 2024 | 0.6195 |
| May 14, 2024 | 0.6613 |
| May 13, 2024 | 0.6746 |
| May 10, 2024 | 0.6496 |
| May 09, 2024 | 0.6563 |
| May 08, 2024 | 0.6563 |
| May 07, 2024 | 0.6579 |
| May 06, 2024 | 0.6679 |
| May 03, 2024 | 0.6613 |
| May 02, 2024 | 0.6396 |
| May 01, 2024 | 0.6429 |
| April 30, 2024 | 0.6179 |
| April 29, 2024 | 0.6195 |
| April 26, 2024 | 0.6195 |
| April 25, 2024 | 0.6162 |
| April 24, 2024 | 0.6179 |
| April 23, 2024 | 0.6229 |
| April 22, 2024 | 0.6128 |
| April 19, 2024 | 0.6212 |
| April 18, 2024 | 0.6179 |
| Date | Value |
|---|---|
| April 17, 2024 | 0.6195 |
| April 16, 2024 | 0.6245 |
| April 15, 2024 | 0.6279 |
| April 12, 2024 | 0.6279 |
| April 11, 2024 | 0.6429 |
| April 10, 2024 | 0.6295 |
| April 09, 2024 | 0.6362 |
| April 08, 2024 | 0.6279 |
| April 05, 2024 | 0.6362 |
| April 04, 2024 | 0.6429 |
| April 03, 2024 | 0.6512 |
| April 02, 2024 | 0.6462 |
| April 01, 2024 | 0.6679 |
| March 28, 2024 | 0.6124 |
| March 27, 2024 | 0.6064 |
| March 26, 2024 | 0.5715 |
| March 25, 2024 | 0.5791 |
| March 22, 2024 | 0.6155 |
| March 21, 2024 | 0.6215 |
| March 20, 2024 | 0.5988 |
| March 19, 2024 | 0.5973 |
| March 18, 2024 | 0.6064 |
| March 15, 2024 | 0.6079 |
| March 14, 2024 | 0.5836 |
| March 13, 2024 | 0.6049 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.3903
Minimum
Mar 24 2023
13.31
Maximum
Feb 08 2021
1.952
Average
0.7225
Median
Apr 27 2022
Price to Book Value Benchmarks
| CEL-SCI Corp | 4.922 |
| AIM ImmunoTech Inc | 5.088 |
| IGC Pharma Inc | 3.710 |
| NovaBay Pharmaceuticals Inc | -- |
| Protalix BioTherapeutics Inc | 3.175 |
Price to Book Value Related Metrics
| PS Ratio | 0.9082 |
| Price | 3.82 |
| Earnings Yield | -51.31% |
| Market Cap | 321.73M |
| Operating PE Ratio | 2.306 |
| Normalized PE Ratio | 2.809 |